Immuno Oncology Assays Market: By Product Type By Technology, Next-generation sequencing, Flow Cytometry Others) By Indication By Application and Region Forecast 2019 - 2030
Immuno Oncology Assays Market size was valued at US$ 2,798.6 million in 2023 growing at a significant CAGR of 12.5% from 2024 to 2030. The global market provides a detailed overview of the market, and that can be segmented by Product Type, by Technology, by Indication, and by Application. By product type, the global market has been segmented into Instruments, Reagents and Kits, Software and Services. The software & services segment is likely to be the largest and fastest-growing Segment in terms of type. Based on technology, the global market is segmented into Immunoassay, Polymerase chain reaction (PCR), Next-generation sequencing (NGS), Flow Cytometry Others. Among these, the Polymerase chain reaction (PCR) segment is expected to have the fastest-growing market during the forecast period 2024-2030.
Based on indication, the global Immuno market is segmented into Breast Cancer, Colorectal Cancer, Lung Cancer Treatment, Melanoma Cancer, Bladder Cancer, Others. The lung cancer segment accounts for the largest share in 2021. Breast cancer segment is the second-largest share during the forecast period 2022-2028. Based on the Application, the segment has been segregated into Clinical Diagnostics, Research Application. The clinical diagnostics segment is expected to dominate other segments in the market.
Study Period
2024-2030Base Year
2023CAGR
12.5%Largest Market
North AmericanFastest Growing Market
Asia-Pacific
In order to diagnose and cure cancer, there is a great demand for research, and immuno-oncology assays play a significant role in this research due to the rise in incidence and prevalence of the disease is burgeon the market growth over the forecast years.
North America held the largest share and is expected to witness the highest market share during the forecast period. It holds a tremendous potential market for global immuno oncology due to the increasing prevalence of cancers and demand for personalized medicine.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 2,798.6 million |
|
Market CAGR |
12.5% |
|
By Product Type |
|
|
By Technology |
|
|
By Indication |
|
|
By Application |
|
|
By Region |
|
Download Free Sample Report
The global immuno oncology assays market size was valued at US$ 2,798.6 million in 2023 and is expected to grow at a CAGR of 12.5% from 2024 to 2030.
Based on technology, the global Immuno Oncology Assays Market is segmented into Immunoassay, Polymerase chain reaction (PCR), Next-generation sequencing (NGS), Flow Cytometry Others. Among these, the Polymerase chain reaction (PCR) segment is expected to have the fastest-growing market during the forecast period 2024-2030.
The key market players are Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Illumina, Inc. (US), NanoString Technologies, Inc. (US), Sartorius AG(Germany), HTG Molecular Diagnostics, Inc. (US), QIAGEN N.V. (Netherlands), Merck Millipore (US), PerkinElmer, Inc. (US), Abbott Laboratories, Inc. (US), Guardant Health, Inc. (US), bioMérieux SA
| 1. Executive Summary |
| 2. Global Immuno Oncology Assays Market Introduction |
| 2.1. Global Immuno Oncology Assays Market - Taxonomy |
| 2.2. Global Immuno Oncology Assays Market -Definitions |
| 2.2.1. By Product Type |
| 2.2.2. By Technology |
| 2.2.3. By Indication |
| 2.2.4. By Application |
| 2.2.5. By Region |
| 3. Global Immuno Oncology Assays Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Immuno Oncology Assays Market Dynamic Factors - Impact Analysis |
| 3.6. Global Immuno Oncology Assays Market - Competition Landscape |
| 4. Global Immuno Oncology Assays Market Analysis, 2019-2023 and Forecast, 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Immuno Oncology Assays Market, By Product Type, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.1. Instruments |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Reagents and Kits |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Software and Services |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Immuno Oncology Assays Market, By Technology, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.1. Immunoassay |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Polymerase chain reaction (PCR) |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Next-generation sequencing (NGS) |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Flow Cytometry |
| 6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Immuno Oncology Assays Market, By Indication, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.1. Breast Cancer |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Colorectal Cancer |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Lung Cancer |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Melanoma Cancer |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Bladder Cancer |
| 7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Others |
| 7.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 8. Global Immuno Oncology Assays Market, By Application, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.1. Clinical Diagnostics |
| 8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Research Application |
| 8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 9. Global Immuno Oncology Assays Market Forecast, By Region, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia-Pacific |
| 9.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Latin America |
| 9.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Middle East and Africa |
| 9.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Global Immuno Oncology Assays Market - Opportunity Analysis Index, By Product Type, Technology, Indication, Application, and Region, 2024-2030 |
| 10. North America Immuno Oncology Assays Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 10.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Instruments |
| 10.1.2. Reagents and Kits |
| 10.1.3. Software and Services |
| 10.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Immunoassay |
| 10.2.2. Polymerase chain reaction (PCR) |
| 10.2.3. Next-generation sequencing (NGS) |
| 10.2.4. Flow Cytometry |
| 10.2.5. Others |
| 10.3. Indication Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Breast Cancer |
| 10.3.2. Colorectal Cancer |
| 10.3.3. Lung Cancer |
| 10.3.4. Melanoma Cancer |
| 10.3.5. Bladder Cancer |
| 10.3.6. Others |
| 10.4. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Clinical Diagnostics |
| 10.4.2. Research Application |
| 10.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.5.1. USA |
| 10.5.2. Canada |
| 10.6. North America Immuno Oncology Assays Market - Opportunity Analysis Index, By Product Type, Technology, Indication, Application, and Country, 2024-2030 |
| 10.7. North America Immuno Oncology Assays Market Dynamics - Trends |
| 11. Europe Immuno Oncology Assays Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 11.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Instruments |
| 11.1.2. Reagents and Kits |
| 11.1.3. Software and Services |
| 11.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Immunoassay |
| 11.2.2. Polymerase chain reaction (PCR) |
| 11.2.3. Next-generation sequencing (NGS) |
| 11.2.4. Flow Cytometry |
| 11.2.5. Others |
| 11.3. Indication Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Breast Cancer |
| 11.3.2. Colorectal Cancer |
| 11.3.3. Lung Cancer |
| 11.3.4. Melanoma Cancer |
| 11.3.5. Bladder Cancer |
| 11.3.6. Others |
| 11.4. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Clinical Diagnostics |
| 11.4.2. Research Application |
| 11.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.5.1. Germany |
| 11.5.2. UK |
| 11.5.3. France |
| 11.5.4. Spain |
| 11.5.5. Italy |
| 11.5.6. Russia |
| 11.5.7. Rest of Europe |
| 11.6. Europe Immuno Oncology Assays Market - Opportunity Analysis Index, By Product Type, Technology, Indication, Application, and Country, 2024-2030 |
| 11.7. Europe Immuno Oncology Assays Market Dynamics - Trends |
| 12. Asia-Pacific Immuno Oncology Assays Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 12.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Instruments |
| 12.1.2. Reagents and Kits |
| 12.1.3. Software and Services |
| 12.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Immunoassay |
| 12.2.2. Polymerase chain reaction (PCR) |
| 12.2.3. Next-generation sequencing (NGS) |
| 12.2.4. Flow Cytometry |
| 12.2.5. Others |
| 12.3. Indication Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Breast Cancer |
| 12.3.2. Colorectal Cancer |
| 12.3.3. Lung Cancer |
| 12.3.4. Melanoma Cancer |
| 12.3.5. Bladder Cancer |
| 12.3.6. Others |
| 12.4. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Clinical Diagnostics |
| 12.4.2. Research Application |
| 12.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.5.1. China |
| 12.5.2. India |
| 12.5.3. Japan |
| 12.5.4. ASEAN |
| 12.5.5. Australia & New Zealand |
| 12.5.6. Rest of Asia-Pacific |
| 12.6. Asia-Pacific Immuno Oncology Assays Market - Opportunity Analysis Index, By Product Type, Technology, Indication, Application, and Country, 2024-2030 |
| 12.7. Asia-Pacific Immuno Oncology Assays Market Dynamics - Trends |
| 13. Latin America Immuno Oncology Assays Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 13.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Instruments |
| 13.1.2. Reagents and Kits |
| 13.1.3. Software and Services |
| 13.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Immunoassay |
| 13.2.2. Polymerase chain reaction (PCR) |
| 13.2.3. Next-generation sequencing (NGS) |
| 13.2.4. Flow Cytometry |
| 13.2.5. Others |
| 13.3. Indication Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Breast Cancer |
| 13.3.2. Colorectal Cancer |
| 13.3.3. Lung Cancer |
| 13.3.4. Melanoma Cancer |
| 13.3.5. Bladder Cancer |
| 13.3.6. Others |
| 13.4. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Clinical Diagnostics |
| 13.4.2. Research Application |
| 13.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.5.1. Brazil |
| 13.5.2. Mexico |
| 13.5.3. Rest of Latin America |
| 13.6. Latin America Immuno Oncology Assays Market - Opportunity Analysis Index, By Product Type, Technology, Indication, Application, and Country, 2024-2030 |
| 13.7. Latin America Immuno Oncology Assays Market Dynamics - Trends |
| 14. Middle East and Africa Immuno Oncology Assays Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 14.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Instruments |
| 14.1.2. Reagents and Kits |
| 14.1.3. Software and Services |
| 14.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1. Immunoassay |
| 14.2.2. Polymerase chain reaction (PCR) |
| 14.2.3. Next-generation sequencing (NGS) |
| 14.2.4. Flow Cytometry |
| 14.2.5. Others |
| 14.3. Indication Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.3.1. Breast Cancer |
| 14.3.2. Colorectal Cancer |
| 14.3.3. Lung Cancer |
| 14.3.4. Melanoma Cancer |
| 14.3.5. Bladder Cancer |
| 14.3.6. Others |
| 14.4. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.4.1. Clinical Diagnostics |
| 14.4.2. Research Application |
| 14.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 14.5.1. Gulf Cooperation Council (GCC) Countries |
| 14.5.2. South Africa |
| 14.5.3. Rest of MEA |
| 14.6. MEA Immuno Oncology Assays Market - Opportunity Analysis Index, By Product Type, Technology, Indication, Application, and Country, 2024-2030 |
| 14.7. MEA Immuno Oncology Assays Market Dynamics - Trends |
| 15. Competition Landscape |
| 15.1. Strategic Dashboard of Top Market Players |
| 15.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 15.2.1. Agilent Technologies, Inc. |
| 15.2.2. Thermo Fisher Scientific, Inc. |
| 15.2.3. PerkinElmer, Inc. |
| 15.2.4. Illumina, Inc. |
| 15.2.5. PerkinElmer, Inc. |
| 15.2.6. Crown Bioscience Inc. |
| 15.2.7. InSphero, Inc. |
| 15.2.8. Merck & Company, Inc. |
| 15.2.9. F.Hoffmann-La Roche Ltd. |
| 15.2.10. HTG Molecular Diagnostics, Inc. |
| 15.2.11. Miltenyi Biotec |
| 16. Research Methodology |
| 17. Key Assumptions and Acronyms |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
